Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

25.70 +0.29 (+1.14%)
Streaming Delayed Price Updated: 1:12 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,312,804
Open 25.62
Bid (Size) 25.68 (2)
Ask (Size) 25.72 (5)
Prev. Close 25.41
Today's Range 25.05 - 26.10
52wk Range 2.100 - 36.91
Shares Outstanding 97,381,774
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour
The selloff came as investors repriced risk across equities amid fears of persistently higher rates, sparked by soft demand at the 20-year Treasury auction. 
Via Benzinga
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Topics Economy Law Enforcement
Exposures Economy Legal Product Safety

Performance

YTD
+40.1%
+40.1%
1 Month
+1.9%
+1.9%
3 Month
+19.0%
+19.0%
6 Month
+38.0%
+38.0%
1 Year
+485.4%
+485.4%

More News

Read More
Got $100? 3 Top Growth Stocks to Buy That Could Double Your Money
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For May 1, 2025
Via Benzinga
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Summit Therapeutics Inc.
Via Business Wire
Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?
Via Benzinga
Can Summit Therapeutics Stock Double Your Money?
Via The Motley Fool
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Via Benzinga
This Soaring Stock Just Delivered More Good News. Time to Buy?
Via The Motley Fool
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025
From Summit Therapeutics Inc.
Via Business Wire
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Is Summit Therapeutics Stock Trading Higher On Monday?
Via Benzinga
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
Via Benzinga
Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back
Via Benzinga
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today
Via The Motley Fool
Exposures Product Safety
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
What's Going On With Summit Therapeutics Stock On Friday?
Via Benzinga
Exposures Product Safety
Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China
From Summit Therapeutics Inc.
Via Business Wire
Top stock movements in today's session.
Via Chartmill
Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Summit Therapeutics to Host First Quarter 2025 Financial Results & Operational Progress Call on May 1, 2025
From Summit Therapeutics Inc.
Via Business Wire
Summit Therapeutics Retail Traders Stoked As Stock Surges On Promising Cancer Drug Trial
Via Stocktwits
Why Summit Therapeutics Rocketed Double-Digits Today
Via The Motley Fool
Topics World Trade
Exposures Tariff
Why Is Summit Therapeutics Stock Soaring On Wednesday?
Via Benzinga

Frequently Asked Questions

Is Summit Therapeutics Inc. - Common Stock publicly traded?
Yes, Summit Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Summit Therapeutics Inc. - Common Stock trade on?
Summit Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Summit Therapeutics Inc. - Common Stock?
The ticker symbol for Summit Therapeutics Inc. - Common Stock is SMMT on the Nasdaq Stock Market
What is the current price of Summit Therapeutics Inc. - Common Stock?
The current price of Summit Therapeutics Inc. - Common Stock is 25.70
When was Summit Therapeutics Inc. - Common Stock last traded?
The last trade of Summit Therapeutics Inc. - Common Stock was at 05/22/25 01:12 PM ET
What is the market capitalization of Summit Therapeutics Inc. - Common Stock?
The market capitalization of Summit Therapeutics Inc. - Common Stock is 2.50B
How many shares of Summit Therapeutics Inc. - Common Stock are outstanding?
Summit Therapeutics Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.